Citations (0)
Keep up to date with the latest research on this topic with citation updates for this article.
Molecular & Cellular Oncology
Volume 9, 2022 - Issue 1
Author’s Views
Tumor suppressor pathways shape EGFR-driven lung tumor progression and response to treatment
Giorgia Foggettia Department of Internal Medicine (Medical Oncology), Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA;b Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, ItalyCorrespondence[email protected] [email protected]
https://orcid.org/0000-0003-1844-1413
https://orcid.org/0000-0003-1844-1413, Chuan Lic Departments of Biology, Stanford University School of Medicine, Stanford, California, USAhttps://orcid.org/0000-0002-4381-3891
https://orcid.org/0000-0002-4381-3891, Hongchen Caid Department of Genetics, Stanford University School of Medicine, Stanford, California, USAhttps://orcid.org/0000-0002-5921-5773
https://orcid.org/0000-0002-5921-5773, Dmitri A. Petrovc Departments of Biology, Stanford University School of Medicine, Stanford, California, USAhttps://orcid.org/0000-0002-3664-9130
https://orcid.org/0000-0002-3664-9130, Monte M. Winslowd Department of Genetics, Stanford University School of Medicine, Stanford, California, USA;e Department of Pathology, Stanford University School of Medicine, Stanford, California, USA;f Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USAhttps://orcid.org/0000-0002-5730-9573
https://orcid.org/0000-0002-5730-9573 & Katerina Politia Department of Internal Medicine (Medical Oncology), Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA;g Department of Pathology, Yale School of Medicine, New Haven, Connecticut, USA;h Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut, USAhttps://orcid.org/0000-0001-6064-4527
https://orcid.org/0000-0001-6064-4527